Joe Newell joins board of directors as part of the company’s ongoing commitment to improving the cell and gene therapy supply chain   

DAYTON, Ohio, Feb. 23, 2022 – CSafe Global, the innovation leader in temperature-controlled container solutions for the transport of life-enhancing pharmaceuticals, announced today that Joe Newell has been appointed to the company’s board of directors. With this appointment the Board will comprise 9 directors.

“We are pleased to welcome Joe to the CSafe board,” said CSafe CEO and board member, Patrick Schafer. “His vast experience from across the biopharma industry, including his deep understanding of the cell and gene therapies space, will be invaluable to CSafe as we grow our business in that sector and further our mission to safely deliver life-enhancing products to patients.”

“Joe is a pivotal addition to our board,” said Bill Mitchell, CSafe Chairman of the Board and Executive in Residence for Frazier Healthcare Partners. “Expanding our portfolio to meet the unique needs of the cell and gene therapy market has been a core strategic focus for CSafe. Joe’s expert guidance in this space will help accelerate our expansion of a truly client-centric solution.”

Mr. Newell has spent his near 30-year career in the pharmaceutical and life sciences industries. He most recently served as Chief Operations Officer for Atara Biotherapeutics, a pioneer in allogeneic T-cell immunotherapies for patients with serious diseases including hematologic cancers, autoimmune disease and solid tumors. At Atara he oversaw Process Sciences, Manufacturing, Quality, Program Management, Alliance Management, and Enterprise Services. Prior to joining Atara, Mr. Newell held leadership roles in manufacturing, operations, supply chain and logistics for multiple industry-leading drug development and pharma services organizations, including Alexion Pharmaceuticals, Amgen, Catalent Pharma Services and Cardinal Health. He holds a bachelor’s degree in Biology from California State Polytechnic University – Pomona.

“I am extremely excited to join the CSafe Global board and work with a seasoned and highly successful executive team,” said Newell. “Csafe is a mission driven company that leads with core values that I appreciate and a true passion for quality and service. The company is well-positioned to deliver an unmatched, holistic cell and gene therapy cold chain portfolio solution and distribution network to help ensure these critical life-saving therapies can reach the patients who need them.”

Brody McCullough, CPA, joins CSafe Global as VP of Finance as the company begins integration of Softbox Systems following acquisition

DAYTON, Ohio, Feb. 8, 2022 – CSafe Global, the innovation leader in temperature-controlled container solutions for the transport of life-enhancing pharmaceuticals, announced today that Brody McCullough, CPA has joined the company as Vice President of Finance.

Mr. McCullough brings more than a decade of diverse experience in accounting and finance ranging from traditional corporate finance to financial planning and analysis (FP&A), transformation and integration. McCullough began his career with EY in their assurance practice. In 2012, shortly after their IPO, McCullough joined Vantiv, a payment processing company and technology provider.  During his tenure, McCullough held several finance leadership roles including establishing a global synergy governance program for the Vantiv acquisition of Worldpay, driving significant value creation for the company. When FIS acquired Worldpay in 2019, he was tapped to lead the FP&A integration with a focus on process efficiency, policy alignment and future-state organizational structure. Most recently, he served as the finance lead for FIS’ Technology Development organization.

In his new role with CSafe, McCullough will focus on driving financial and business analytics to enable strategic decisions relevant to capital planning/investment, product roadmaps, development resource capacity and demand prioritization. He will also lend his considerable expertise in the acquisition process to CSafe’s ongoing integration with Softbox Systems as part of CSafe’s senior leadership team.

“This is a critical time for our business and making data-driven decisions for future development and investment is essential. Brody’s expertise in FP&A technology and analytics will help us generate a holistic view of potential investments in new products and locations as our business grows,” said CSafe CEO, Patrick Schafer of the decision to add the new role. “His experience with acquisitions and integrations is a timely bonus that will certainly benefit the process.”

Mr. McCullough earned his bachelor’s in accounting, finance and management from the University of Kentucky and is a certified public accountant.

CSafe now offers real-time visibility and online ordering for VIP Parcel and Cell & Gene Solutions.   

DAYTON, Ohio, Jan. 5, 2022 – CSafe Global, the innovation leader in temperature-controlled solutions for the pharmaceutical industry, announced today it has expanded its real-time shipment visibility platform and technology to the company’s VIP Parcel and Cell & Gene portfolios.

Customers who choose to include a monitoring device in their VIP thermal shippers, will have 24/7 access to real-time data and the option to receive alerts via email, SMS or in the platform for:

• Payload temperature
• Route deviation / delay
• Ambient temperature
• Ambient humidity
• Shock event
• Tilt event

The online ordering and visibility platform built in collaboration with Cloudleaf, Inc. has been designed to work seamlessly with CSafe’s Retest & Reuse program. Additional features and benefits include:

• Place and track new orders
• View historic order data
• Simplify tracking by connecting multiple shipment legs with composite shipment features
• Customize real-time alerts
• Customize and save locations for routes
• Access historical shipments
• Receive GDP compliant standard shipment report

CSafe customers who don’t take advantage of the real-time monitoring in VIP Parcel solutions will still have access to the online ordering platform and the ability to track parcel shipments in one place with integrated carrier milestone tracking for approved carriers.

“This completes the next major milestone in this innovation initiative, and I am pleased with the service we are now able to offer our VIP Parcel and Cell & Gene customers,” said Patrick Schafer, CSafe CEO. “With this system in place, we are well-positioned to serve any customer need and provide full transparency for their shipments.”

DAYTON, Ohio, US and LONG CRENDON, Buckinghamshire, UK, December 15, 2021 – CSafe Global, the leader in temperature-controlled container solutions for the pharmaceutical industry, announced today that it has acquired Softbox Systems, a provider of passive temperature-controlled packaging solutions for the pharmaceutical, life science and cold chain logistics industries, significantly enhancing CSafe’s passive product portfolio. Together, they will provide the most comprehensive suite of thermal shipping solutions and become a one-stop-shop for all pharmaceutical cold chain shipping needs, enabling delivery of critical temperature-sensitive products, including next generation biologics, cell and gene therapy, and mRNA therapies such as the COVID-19 vaccine.

The combined company, which will operate globally under the CSafe brand, will be the only cold chain platform with an end-to-end active air cargo and passive temperature-controlled packaging business spanning the complete spectrum of cold chain shipping solutions for the pharmaceutical and life sciences industries. Softbox’s well-regarded brands in the passive container space, such as SilverSkin, Silverpod and Tempcell, complement CSafe’s leading active product portfolio, particularly within air cargo. The acquisition will unlock opportunities for innovation as well as enhance CSafe’s sustainable and eco-friendly offerings, with new reusable and recyclable pallet and parcel solutions.

Around the globe, a large industry pipeline of life-saving pharmaceutical therapies with strict temperature profiles is accelerating the need for reliable, temperature-controlled shipping solutions. Moreover, future pharmaceutical advances will require a new generation of qualified fit-for-purpose packaging, along with sophisticated tracking technology, that also helps customers meet their sustainability and recycling goals.

“Through this combination, we will be the partner of choice for cold chain delivery of high value, temperature sensitive pharmaceutical therapies. Both CSafe and Softbox have proven to be reliable partners for customers seeking a secure way to deliver their life-enhancing products around the world,” said Patrick Schafer, CSafe CEO. “We’re thrilled to now offer our customers a platform that provides everything from the highest quality packaging to AI-enabled thermal and kinetic monitoring and logistics management.”

“Our businesses are each rooted in a commitment to excellent customer service and high product quality, which made this combination a natural fit,” said Kevin Valentine, CEO of Softbox. “Together we will proudly continue to partner with our global Pharmaceutical customers to devise and deliver the best solutions for their evolving cold chain shipping needs, supporting the delivery of temperature sensitive lifesaving medicines and vaccines.

“With the addition of Softbox’s product portfolio, CSafe strengthens its global infrastructure across air and ground while expanding its offerings for parcel delivery, all supported by the most advanced technology infrastructure,” said Todd Abbrecht, Co-CEO of Thomas H. Lee Partners, which first invested in CSafe in 2016. “We see an incredible opportunity for the combined company to serve as the international partner of choice for cold chain shipping solutions and remain on the forefront of innovation in the industry.”

“The acquisition of Softbox advances CSafe’s strategy to be the leading cold chain solutions provider with a full suite of products and services to meet the needs of its pharmaceutical customers around the globe,” said Ben Magnano, Co-Managing Partner of Frazier Healthcare Partners. “CSafe is an excellent platform to build upon and we, alongside our partners at THL, will continue to make investments to further strengthen the Company’s leadership position in pharmaceutical cold chain.”

As part of the acquisition, Softbox CEO Kevin Valentine will assume the role of president of CSafe’s Passive Temperature Controlled Packaging Division.

Terms of the transaction were not disclosed.

Media Contact:

For CSafe Global and Softbox Systems:
Lori Conaway
+1 405.633.2344
lconaway@csafeglobal.com

About CSafe Global

CSafe Global provides end-to-end thermal shipping solutions to the pharmaceutical and life science industries worldwide. An industry innovator, CSafe is the only provider of both active and passive solutions and offers AI-enabled lease forecasting to ensure active container availability and real-time shipment visibility for active and passive containers. CSafe provides industry-leading maintenance and reuse programs ensuring superior product performance and alignment with customer sustainability objectives. With a presence in 150 countries, 24/7 support and 100% container availability, CSafe is well-positioned to be the partner of choice in the cold chain. csafeglobal.com

About Softbox

Softbox is an award-winning temperature control packaging innovator that has been designing and producing high performance passive temperature control packaging solutions for over 25 years. We offer consistent quality to our clients from our strategically located global manufacturing sites throughout Europe, Americas, India and Asia Pacific.

We have formed long standing partnerships with the world’s leading pharmaceutical, clinical research, biotech and logistics companies, and apply innovative thinking to overcome the challenges that our clients face in managing the Cold Chain when shipping temperature sensitive clinical trial and commercialised products.

For more information about Softbox, visit www.softboxsystems.com

About Thomas H. Lee Partners

Thomas H. Lee Partners, L.P. (“THL”) is a premier private equity firm investing in middle-market growth companies exclusively in three sectors: Financial Services, Healthcare, and Technology & Business Solutions. THL couples deep sector expertise through our Identified Sector Opportunity (“ISO”) process with dedicated internal operating resources from our Strategic Resource Group (“SRG”) to transform and build great companies of lasting value in partnership with management. The Firm’s domain expertise and resources help to build great companies with an aim to accelerate growth, improve operations and drive long-term sustainable value. Since 1974, THL has raised more than $30 billion of equity capital, invested in over 160 companies and completed more than 500 add-on acquisitions representing an aggregate enterprise value at acquisition of over $210 billion. For more information, please visit www.thl.com.

About Frazier Healthcare Partners:

Founded in 1991, Frazier Healthcare Partners is a leading provider of growth and venture capital to healthcare companies. With over $7 billion in total capital raised, Frazier has invested in more than 200 companies with transaction types ranging from buyouts of profitable healthcare services companies to venture capital and company creation. Frazier has a philosophy of partnering with strong management teams while leveraging its internal operating resources and network to build exceptional companies. Frazier has offices in Seattle, WA, and Menlo Park, CA, and invests broadly across the U.S., Canada, and Europe. For more information about Frazier Healthcare Partners, visit www.frazierhealthcare.com.

The 16,000 square-foot facility expansion will allow CSafe to hold more active containers in inventory to meet customer demands in ORD.

DAYTON, Ohio, Aug. 31, 2021 – CSafe Global, the innovation leader in temperature-controlled container solutions for the transport of life-enhancing pharmaceuticals, continues expanding to meet customer demand with a move to a new location in Chicago that more than triples the size of their former location in the area.

The Chicago facility provides 23,000 square-feet of newly constructed warehouse space for CSafe RKN and RAP storage and operations. “Chicago is a crucial hub for a number of air cargo lanes internationally and domestically. Expanding from 7,000 to 23,000 square-feet allows us to hold and service significantly more active containers to meet current and future customer demand,” noted Tom Weir, CSafe COO.

The new Chicago service center – now the largest CSafe Global location in the United States – is fully operational and serving CSafe customers from 07:30 to 16:00 daily. CSafe continues expanding its presence worldwide by investing in best-in-class facilities to provide the best service possible to customers in their local area.

DAYTON, Ohio, March 9, 2021 – CSafe Global, the innovation leader in temperature-controlled container solutions for the transport of life-enhancing pharmaceuticals, has been recognized as United Cargo’s Service Partner of the Year for 2020.

The honor was presented during a virtual awards ceremony at United’s Worldwide Cargo Meeting held annually in January. The Service Partner of the Year award is given to a partner company who positively impacted United Cargo’s global business and achieved overall outstanding operational performance.

“We pride ourselves on providing unmatched support and service to our customers and we are honored to be recognized by United Cargo,” said Patrick Schafer, CSafe CEO. “I want to thank United Cargo and Jan Krems for this award. And a special note of thanks goes to our own Jez Palmer, senior director of partner alliance (airlines) for CSafe, for his ongoing dedication to building and maintaining strong relationships with our airline partners.”

“United Cargo has played a major role in transporting vital commodities to global communities since the beginning of the COVID-19 pandemic. Safely delivering these essential goods is not possible without strong service partners like CSafe who share our same commitment to providing customers with the highest level of service,” said United Cargo President Jan Krems. “CSafe has been an integral partner in helping us protect and deliver critical temperature-controlled shipments, which is more necessary now than ever before.”

“On behalf of the CSafe team all around the world, I would like to say thank you to United Cargo for this award, highlighting the Specialty Products team under Manu Jacob’s stewardship.  When 2020 began nobody knew what was about to happen and the far-reaching impact the COVID-19 pandemic would have. The principles of partnership and collaboration have come to the fore to change the lives of patients all around the world, in a time when this has become more important than ever,” Palmer said. “This year will undoubtedly be another unique year, and CSafe looks forward to continuing to partner with United Cargo.”

CSafe has engaged local partnerships to establish its first hub operation in Luxembourg and a third in Italy to support local customers.

CSafe Global, the innovation leader in temperature-controlled container solutions for the transport of life-enhancing pharmaceuticals, is once again expanding their global footprint opening two new hub operations in Luxembourg and Florence, Italy.

Partnering with DB Schenker in Luxembourg, CSafe has approximately 2,500 square-feet / 232 square-meters of warehouse space to clean and store RKN and RAP containers. In Florence, the company has extended an ongoing partnership with BCube to secure approximately 10,000 square-feet / 929 square-meters for CSafe containers.

With the addition of these new hub locations, Europe now has the most CSafe operations facilities in the world. “These locations round out a robust CSafe network across Europe,” noted Tom Weir, CSafe COO. “We continue to evaluate the need for additional locations in Europe and around the world to ensure we make the most strategic investments that will optimize operations and service for our customers,” he continued.

CSafe continues to deliver on its mission to the highest quality temperature-controlled containers in the industry to ensure pharmaceuticals and biologics are delivered to patients in optimal condition for maximum efficacy. By investing in best-in-class facilities in strategic locations worldwide, CSafe can provide top tier service to customers in their local area.

Through a partnership with C.H. Robinson, CSafe will establish hub operations in Beijing and Guangzhou to support local customers.

DAYTON, Ohio, Feb. 3, 2021 – CSafe Global, the innovation leader in temperature-controlled container solutions for the transport of life-enhancing pharmaceuticals, continues to expand operations across Asia opening two new hub operations in Beijing and Guangzhou, China.

The Beijing (PEK) facility will provide 500 sqm (5382 sq. ft.) of warehouse space to clean and store CSafe RKN and RAP containers. CSafe will have 400 sqm (4305 sq. ft.) in the Guangzhou (CAN) facility. This strategic partnership with C.H. Robinson provides CSafe access to their extensive network and logistics experience. C.H. Robinson’s vast network of locations across China – including 19 of the major cities – gives CSafe the flexibility to easily expand and provide containers to customers in key locations quickly.

These two new facilities bring CSafe’s total station count to 11 across the APAC region with more to come in 2021. “Adding these to our established operations in Shanghai and Hong Kong, we are able to easily supply CSafe containers anywhere in mainland China,” said Tom Weir, CSafe Global COO. “Our team is also working on agreements in several other locations across the region to establish additional hubs and comprehensive service centers for container maintenance and repairs this year in other major cities in China. We are very strategic about where we establish hubs and service centers to ensure we invest wisely and always optimize operations and service for our customers,” he continued.

CSafe continues to deliver on its mission to the highest quality temperature-controlled containers in the industry to ensure pharmaceuticals and biologics are delivered to patients in optimal condition for maximum efficacy. By investing in best-in-class facilities in strategic locations worldwide, CSafe can provide top tier service to customers in their local area.

通过与 C.H. Robinson 建立的伙伴关系，CSafe 将在北京和广州新建两个运营枢纽，以便为当地客户提供支持。

2021 年 2 月 3 日于美国俄亥俄州代顿市——CSafe Global 是一家供应温控集装箱的领先供应商，公司产品适用于运输各种增益生命的药剂产品。该公司继续在亚洲扩展业务，包括在中国的北京和广州新建两个运营枢纽。

位于北京（机场代号：PEK）的运营枢纽面积达 500 平方米（5,382 平方英尺），可为 CSafe 的 RKN 和 RAP 集装箱提供清洁和存储等服务。CSafe 在广州（机场代号：CAN）的运营枢纽将有 400 平方米（4,305 平方英尺）的面积。这次与 C.H. Robinson 建立的战略合作伙伴关系为 CSafe 带来了广大的网络和后勤运营经验。C.H. Robinson 在中国有笼大的网络——覆盖了 19 个大城市；CSafe 也因此可以利用这个网络在各个主要城市扩展，并迅速向位于各大城市的客户提供集装箱。

这两个新设施使 CSafe 目前在亚太地区所拥有的据点数量增加到 11 个；该公司也将在 2021 年继续扩展在中国的业务。CSafe Global 的首席运营官 Tom Weir 说：“我们在现有的上海和香港业务之外新增了这两个枢纽，让我们能为中国各地提供 CSafe 的集装箱。我们的团队也同时在中国其他地点筹备运营据点，希望能在今年内建立更多的集装箱运营中心和服务中心，为中国其他大城市提供集装箱的维修服务。我们在筹建运营和服务中心时，都以战略的角度进行选址；这能确保我们明智地投资未来，同时为我们的客户优化运营和服务。”

CSafe 的使命是为业界提供最高质量的温控集装箱，以便确保所有的药物和生物制剂都能以最佳的状态交付到病患手中，最终达到最佳的疗效。通过在各大重要地点投资一流设施，CSafe可为当地客户提供顶级的服务。